← back to search

Michael D. Buck

The Francis Crick Institute ·
Area of research
Immunology · Health Information Management
Research interest
Research interests include Immune Cell Function and Interaction, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and Electronic Health Records Systems.
h-index
36
citations
12,709
works
83
NIH funding
primary concept
email

Recent publications

The dietary sweetener sucralose is a negative modulator of T cell-mediated responses
Nature 2023cited by 107position: middledoi
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
The Lancet 2020cited by 245position: middledoi
Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2
Immunity 2018cited by 105position: middledoi
Metabolic Reprogramming Overcomes T Cell Inhibition By AML Cells
Blood 2018cited by 0position: middledoi
Metabolic Instruction of Immunity
Cell 2017cited by 1,146position: firstdoi
Mitochondrial Priming by CD28
Cell 2017cited by 281position: middledoi
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Cell 2016cited by 1,417position: firstdoi
Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function
Immunity 2016cited by 334position: middledoi
Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation
Nature Immunology 2016cited by 279position: middledoi
Autophagy Genes Enhance Murine Gammaherpesvirus 68 Reactivation from Latency by Preventing Virus-Induced Systemic Inflammation
Cell Host & Microbe 2016cited by 58position: middledoi
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Cell 2015cited by 3,177position: middledoi
T cell metabolism drives immunity
The Journal of Experimental Medicine 2015cited by 1,140position: firstdoi
Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development
Immunity 2014cited by 774position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Erika L. Pearce · University of Freiburg9 papers (2014–2018)David O’Sullivan · Seoul National University of Education6 papers (2014–2018)Jing Qiu · Guangzhou University5 papers (2014–2018)Edward J. Pearce · Bloomberg (United States)5 papers (2014–2018)Chih‐Hao Chang · University of California, San Francisco4 papers (2014–2016)Jonathan D. Curtis · Bloomberg (United States)4 papers (2014–2018)Qiongyu Chen · Jackson Laboratory3 papers (2015–2016)Gerritje J. W. van der Windt · Amsterdam University Medical Centers3 papers (2014–2016)Stanley Ching‐Cheng Huang · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute3 papers (2014–2018)David E. Sanin · Bloomberg (United States)3 papers (2016–2018)Amber M. Smith · University of Tennessee Health Science Center2 papers (2014–2016)Christina M. O’Neill · Washington University in St. Louis2 papers (2016–2018) · 2 papers (2016–2018)Duojiao Wu · Fudan University2 papers (2016–2018)Maxim N. Artyomov · ITMO University2 papers (2016–2016) · 1 papers (2016–2016)Zhi‐Ping Liu · Shandong University1 papers (2016–2016)Elena Tonc · Hamilton College1 papers (2015–2015)Tatsuya Saitoh · Southwestern Medical Center1 papers (2016–2016)Francesc Baixauli · Department of Biomedicine Basel1 papers (2018–2018)